UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Altered EBV specific immune control in multiple sclerosis

Journal of neuroimmunology, 2024-05, Vol.390, p.578343, Article 578343

Münz, Christian

2024

Volltextzugriff (PDF)

Vaccination against the Epstein–Barr virus

Cellular and molecular life sciences : CMLS, 2020-11, Vol.77 (21), p.4315-4324

2020

Volltextzugriff (PDF)

Compartmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs

PLoS pathogens, 2016-08, Vol.12 (8), p.e1005799-e1005799

2016

Volltextzugriff (PDF)

Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors

PLoS pathogens, 2021-12, Vol.17 (12), p.e1010137-e1010137

2021

Volltextzugriff (PDF)

Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection

PLoS pathogens, 2018-09, Vol.14 (9), p.e1007110-e1007110

2018

Volltextzugriff (PDF)

Role of human natural killer cells during Epstein-Barr virus infection

Critical reviews in immunology, 2014, Vol.34 (6), p.501-507

Muenz, Christian

2014

Volltextzugriff (PDF)

A distinct subpopulation of human NK cells restricts B cell transformation by EBV

The Journal of immunology (1950), 2013-11, Vol.191 (10), p.4989-4995

2013

Volltextzugriff (PDF)

Redirecting T Cells against Epstein-Barr Virus Infection and Associated Oncogenesis

Cells (Basel, Switzerland), 2020-06, Vol.9 (6), p.1400

Münz, Christian

2020

Volltextzugriff (PDF)

Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components

Frontiers in immunology, 2018-02, Vol.9, p.238-238

Münz, Christian

2018

Volltextzugriff (PDF)

Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15

European journal of immunology, 2021-01, Vol.51 (1), p.64-75

2021

Volltextzugriff (PDF)

Patients with Epstein Barr virus‐positive lymphomas have decreased CD4+ T‐cell responses to the viral nuclear antigen 1

International journal of cancer, 2008-12, Vol.123 (12), p.2824-2831

2008

Volltextzugriff (PDF)

CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo

PLoS pathogens, 2019-05, Vol.15 (5), p.e1007748-e1007748

2019

Volltextzugriff (PDF)

Editorial: EBV-induced T cell immunity in cancers

Frontiers in immunology, 2024-07, Vol.15, p.1454792

2024

Volltextzugriff (PDF)

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells

The Journal of experimental medicine, 2017-06, Vol.214 (6), p.1827-1841

2017

Volltextzugriff (PDF)

Cognate HLA absence in trans diminishes human NK cell education

The Journal of clinical investigation, 2016-10, Vol.126 (10), p.3772-3782

2016

Volltextzugriff (PDF)

Infectious diseases in humanized mice

European journal of immunology, 2013-09, Vol.43 (9), p.2246-2254

2013

Volltextzugriff (PDF)

Innate immune responses against Epstein Barr virus infection

Journal of leukocyte biology, 2013-12, Vol.94 (6), p.1185-1190

2013

Volltextzugriff (PDF)

Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study

PloS one, 2016-12, Vol.11 (12), p.e0167841-e0167841

2016

Volltextzugriff (PDF)

KSHV infection of B cells primes protective T cell responses in humanized mice

Nature communications, 2024-06, Vol.15 (1), p.4841-13

2024

Volltextzugriff (PDF)

Epstein-Barr virus: Environmental trigger of multiple sclerosis?

Journal of virology, 2007-07, Vol.81 (13), p.6777-6784

2007

Volltextzugriff (PDF)

Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses

FEMS microbiology reviews, 2019-03, Vol.43 (2), p.181-192

2019

Volltextzugriff (PDF)

Immune escape by Epstein–Barr virus associated malignancies

Seminars in cancer biology, 2008-12, Vol.18 (6), p.381-387

2008

Volltextzugriff (PDF)

Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target

The Journal of experimental medicine, 2004-05, Vol.199 (10), p.1301-1304

Muenz, C

2004

Volltextzugriff (PDF)

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

The Journal of experimental medicine, 2009-06, Vol.206 (6), p.1423-1434

2009

Volltextzugriff (PDF)

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis

Brain (London, England : 1878), 2006-06, Vol.129 (6), p.1493-1506

2006

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaEpstein-Barr Virus

ThemaHerpesvirus 4, Human - Immunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)

Erscheinungsjahr

n.n

Thema

Humans
(27)
Science & Technology
(22)
Life Sciences & Biomedicine
(20)
Epstein-Barr Virus Infections - Immunology
(19)
Immunology
(15)
Animals
(11)
Infections
(10)
Lymphocytes T
(10)
Cd8-Positive T-Lymphocytes - Immunology
(9)
Lymphocytes
(9)
T Cells
(9)
Infectious Mononucleosis
(8)
Viruses
(8)
Lymphoma
(7)
Antigens
(6)
Antigens, Viral - Immunology
(6)
B-Lymphocytes - Immunology
(6)
Cd4-Positive T-Lymphocytes - Immunology
(6)

13 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Altered EBV specific immune control in multiple sclerosis

Vaccination against the Epstein–Barr virus

Compartmentalization of Total and Virus-Specific Tissue-Resident Memory CD8+ T Cells in Human Lymphoid Organs

Cytotoxic CD4+ T-cells specific for EBV capsid antigen BORF1 are maintained in long-term latently infected healthy donors

Proteome-wide analysis of CD8+ T cell responses to EBV reveals differences between primary and persistent infection

Role of human natural killer cells during Epstein-Barr virus infection

A distinct subpopulation of human NK cells restricts B cell transformation by EBV

Redirecting T Cells against Epstein-Barr Virus Infection and Associated Oncogenesis

Human γ-Herpesvirus Infection, Tumorigenesis, and Immune Control in Mice with Reconstituted Human Immune System Components

Attenuated immune control of Epstein–Barr virus in humanized mice is associated with the multiple sclerosis risk factor HLA‐DR15

Patients with Epstein Barr virus‐positive lymphomas have decreased CD4+ T‐cell responses to the viral nuclear antigen 1

CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo

Editorial: EBV-induced T cell immunity in cancers

Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells

Cognate HLA absence in trans diminishes human NK cell education

Infectious diseases in humanized mice

Innate immune responses against Epstein Barr virus infection

Regulatory T Cells in Endemic Burkitt Lymphoma Patients Are Associated with Poor Outcomes: A Prospective, Longitudinal Study

KSHV infection of B cells primes protective T cell responses in humanized mice

Epstein-Barr virus: Environmental trigger of multiple sclerosis?

Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses

Immune escape by Epstein–Barr virus associated malignancies

Epstein-barr virus nuclear antigen 1: from immunologically invisible to a promising T cell target

Priming of protective T cell responses against virus-induced tumors in mice with human immune system components

Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis

Aktive Filter

Suchergebnisse filtern